Skip to content

LSD: all studies

Page 265 of 282: studies 2,641 to 2,650 of 2,815, newest first. Back to the LSD overview

Research

Psychedelic Effects of Ketamine in Healthy Volunteers

Anesthesiology 1998 Andrew t. Bowdle, Allen d. Radant, Deborah s. Cowley et al. 371 citations

Background Ketamine has been associated with a unique spectrum of subjective "psychedelic" effects in patients emerging from anesthesia. This study quantified these effects of ketamine and related them to steady-state plasma concentrations. Methods Ketamine or saline was administered in a single-blinded crossover protocol to 10 psychiatrically healthy volunteers using computer-assisted...

DOI: 10.1097/00000542-199801000-00015 (opens in new tab) Ketamine ketamine levels Ketamine concentrations Potent psychedelic compounds Dose-response relationship direct +9

Treatment of alcoholism using psychedelic drugs: a review of the program of research.

Journal of Psychoactive Drugs 1998 M Mangini 107 citations

Following Albert Hofmann's discovery of LSD's psychoactive properties in 1943, and previous to their scheduling as controlled substances, the psychedelic drugs were widely studied--six international conferences and hundreds of papers discussed their potential therapeutic usefulness. The observation that the frightening experience of delirium tremens sometimes led alcoholics to moderate their...

DOI: 10.1080/02791072.1998.10399714 (opens in new tab) Full text (opens in new tab) Psychedelic therapy LSD Treatment Hallucinogen therapy Mind-altering drug therapy +16

Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination.

Pharmacology, Biochemistry, and Behavior August 1997 L E Baker, M M Taylor

The phenylisopropylamine derivatives 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) have been compared to both psychostimulants and hallucinogens in drug discrimination investigations. The stereoisomers of these compounds, in particular those of MDA, appear to produce differential effects. Previous studies have demonstrated that animals trained to discriminate...

Drug-drug discrimination: stimulus properties of drugs of abuse upon a serotonergic-dopaminergic continuum.

Pharmacology, Biochemistry, and Behavior January 1997 M D Schechter

Ten male N/Nih rats were trained to discriminate between the interoceptive cues produced by the purportedly dopaminergically-mediated drug d-amphetamine at 0.4 mg/kg intraperitoneally administered 20 min prior to training and those produced by the purportedly serotonergically-active agent norfenfluramine at 0.7 mg/kg. Once this discrimination was successfully acquired, the rats were tested with...

Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.

Journal of Neurochemistry December 1, 1996 R A Newton, S L Phipps, T P Flanigan et al. 46 citations

Stable transfection of the human neuroblastoma cell line SH-SY5Y with the human 5-hydroxytryptamine2A (5-HT2A) or 5-HT2C receptor cDNA produced cell lines demonstrating ligand affinities that correlated closely with those for the corresponding endogenous receptors in human frontal cortex and choroid plexus, respectively. Stimulation of the recombinant receptors by 5-HT induced phosphoinositide...

The psychopharmacology of hallucinogens.

Neuropsychopharmacology April 1, 1996 H D Abraham, A M Aldridge, P Gogia 155 citations

Hallucinogenic drugs have been inhaled, ingested, worshipped, and reviled since prehistory. With the purification and synthesis of bontanical preparations and the ensuing discovery of chemically unique agents, hope was raised regarding their therapeutic potential, but this hope has been clouded by an epidemic of abuse and an inventory of adverse effects. This review examines aspects of that...

Dihydrobenzofuran Analogues of Hallucinogens. 3. Models of 4-Substituted (2,5-Dimethoxyphenyl)alkylamine Derivatives with Rigidified Methoxy Groups

Journal of Medicinal Chemistry 1996 Aaron Monte, Danuta Marona‐lewicka, Matthew Parker et al. 106 citations

Tetrahydrobenzodifuran functionalities were employed as conformationally restricted bioisosteres of the aromatic methoxy groups in prototypical hallucinogenic phenylalkylamines 1 and 2. Thus, a series of 8-substituted 1-(2,3,6,7-tetrahydrobenzo[1,2-b:4,5-b']difuran-4-yl)-2-aminoal kanes (7a-e) were prepared and evaluated for activity in the two-lever drug discrimination paradigm in rats trained...

The Use of Hallucinogens in the Treatment of Addiction

Addiction Research & Theory 1996 John H. Halpern 63 citations

AbstractResearch into treating drug dependence with hallucinogens, although promising, ended with questions still unanswered because of varying, in some cases skeptical, methodology and insufficient adherence to a double-blind, placebo-controlled design. Interest is again emerging, especially with the recent patenting in the United States of ibogaine for its apparent anti-craving properties. A...

5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine.

Psychopharmacology December 1995 David Fiorella, Scott Helsley, R A Rabin et al.

The present study was designed to investigate the hypothesis that agonist interactions at 5-HT2C receptors mediate the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP). Three structural classes of compounds have been described to stimulate increases in phosphoinositide (PI) hydrolysis at the 5-HT2C receptor site: phenylpiperazines, phenylalkylamines, and indolamines. Four...

Anatomic and Behavioral Aspects of Frontal‐Subcortical Circuitsa

Annals of the New York Academy of Sciences December 1, 1995 Jeffrey L. Cummings 362 citations

Frontal-subcortical circuits provide a comprehensive framework for understanding the anatomy, biochemistry, and pharmacology of behavior. The three principal behaviorally relevant circuits originate in the dorsolateral prefrontal cortex, orbitofrontal cortex, and anterior cingulate cortex, respectively. Circuit-specific marker behaviors associated with each circuit are executive dysfunction...

DOI: 10.1111/j.1749-6632.1995.tb38127.x (opens in new tab) Disinhibition Dorsolateral prefrontal cortex Frontal lobe Orbitofrontal cortex +3